China Drug Price Cuts Offset by Volume Growth

by Sam Fazeli, Bloomberg Industries Europe

Price cuts that were enforced earlier this year in China have been offset by volume growth, minimizing the challenge for pharmaceutical companies. A 15 percent average price cut was instituted across the essential drug list on February 1, with larger reductions for some more expensive drugs up to 20 percent.

 

Read More >>>

 

Bloomberg BRIEF Newsletters